据墨西哥和古巴的研究者报道，免疫调节转移因子（transferfactor）较阿昔洛韦（aci－clovir）能更有效地减少带状疮疹的疼痛感。在这一研究中，28例带状疮疹病人皮下注射转移因子一日1次（14例）或口服阿昔洛韦400mg，一日5次，治疗7天。随后病人再随访14天。与对照组相比，本 Researchers in Mexico and Cuba have reported that immunomodulatory transfer factors are more effective in reducing the pain associated with band-shaped sores than aci-clovir. In this study, 28 patients with cutaneous eczema were given subcutaneous injection of transfer factor once a day (n = 14) or acyclovir 400 mg orally for 5 days for 7 days. The patient was followed up for a further 14 days. Compared with the control group, this